Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+8.5%
5Y CAGR+23.6%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+8.5%/yr
vs +53.5%/yr prior
5Y CAGR
+23.6%/yr
Recent deceleration
Acceleration
-45.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.9x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $7.66M | +27.5% |
| 2024 | $6.01M | +8.7% |
| 2023 | $5.53M | -7.9% |
| 2022 | $6.00M | +40.3% |
| 2021 | $4.28M | +61.3% |
| 2020 | $2.65M | -3.0% |
| 2019 | $2.74M | +153.0% |
| 2018 | $1.08M | - |